Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA. (2019)
Attributed to:
Future Vaccine Manufacturing Hub: Advancing the manufacture and deployment of cost effective vaccines
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2019.04.043
PubMed Identifier: 31071377
Publication URI: http://europepmc.org/abstract/MED/31071377
Type: Journal Article/Review
Volume: 304
Parent Publication: Journal of controlled release : official journal of the Controlled Release Society
ISSN: 0168-3659